Bioforum the Data Masters has acquired the business assets of TechnoSTAT. A data management and biostatistics CRO with more than two decades of experience serving pharmaceutical, medical device, and biotechnology research sponsors worldwide, TechnoSTAT brings complementary expertise and resources to Bioforum, bolstering its team of clinical trial subject-matter experts and industry-leading services and solutions designed to optimize and automate biometric processes.
Under the terms of the agreement, TechnoSTAT’s workforce will join Bioforum and TechnoSTAT customers will have the opportunity to seamlessly transition to Bioforum. The exclusive deal is part of Bioforum’s ongoing efforts to further enrich its clinical data management, biostatistics, statistical programming, and medical writing services, as well as solutions designed to power the automation of key biometric study processes. These include Bioforum’s technology-enabled tools for visual analytics (BioGrid), SDTM conversation (JetConvert), and risk analysis and validation (Validify).
“With this acquisition, Bioforum is addressing the increasing market demand for high-quality biometrics services and solutions to help transform complex clinical trial data into accurate, understandable, and actionable results,” said Amir Malka, Bioforum’s CEO and Co-Founder. “We are delighted to welcome TechnoSTAT to the Bioforum family and expand our talent pool and operational capabilities in many areas to support both early-stage and established companies conducting research studies.”
Tal Zuker, CEO of TechnoSTAT, added: “Ensuring data quality, integrity, and compliance with the requirements of regulatory authorities is essential to the success of every clinical trial and, therefore, the health of patients. We are thrilled to join forces with Bioforum and leverage our collective strengths to provide enhanced solutions that drive value and innovation for clinical trials sponsors and the patients we all serve.”
About TechnoSTAT
TechnoSTAT provides a wide spectrum of integrated services for biomedical companies, with an emphasis on startups. We are proud of our track record of success, which includes dozens of regulatory approvals in the United States and Europe. Our highly experienced team holds an accumulated wealth of knowledge while remaining at the forefront of changes in regulatory demands in an ever-evolving world of clinical research and biostatistics methods.
Our mission is to continue providing our outstanding expertise as a reliable partner, attentive to clients’ needs, and guiding them to achieve their goals by responding efficiently and rapidly with tailor-made solutions.